https://orcid.org/0000-0001-8880-0392
References
- Zheng Z, Li G, Liao F, Zhang L, Wang X, Fang Z, Chen Q, Liu H, Hu L. Seroconversion of hepatitis B surface antigen among those with previously successful immune response in Southern China. Hum Vaccin Immunother. 2020 Sep 22;1–7. doi:10.1080/21645515.2020.1801076.
- Zhao H, Zhou YH. Revaccination against hepatitis B in late teenagers who received vaccination during infancy: yes or no? Hum Vaccin Immunother. 2018;14(2):456–63. doi:10.1080/21645515.2017.1397243.
- Lin X, Yang J, Lu H, Zhou Y, Zhou G, Wu H, Xu C, Wu Q, Liu J, Chen S, et al. Minimization of hepatitis B infection among children in Jiangsu, China, 12 years after integration of hepatitis B vaccine into the expanded program on immunization. Vaccine. 2016;34(51):6458–63. doi:10.1016/j.vaccine.2016.11.022.
- Cui F, Shen L, Li L, Wang H, Wang F, Bi S, Liu J, Zhang G, Wang F, Zheng H, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–72. doi:10.3201/eid2305.161477.
- Zhao H, Zhou X, Zhou YH. Hepatitis B vaccine development and implementation. Hum Vaccin Immunother. 2020;16(7):1533–44. doi:10.1080/21645515.2020.1732166.
- Trevisan A, Frasson C, De Nuzzo D, Nicolli A, Scapellato ML. Significance of anti-HB levels below 10 IU/L after vaccination against hepatitis B in infancy or adolescence: an update in relation to sex. Hum Vaccin Immunother. 2020;16(2):460–64. doi:10.1080/21645515.2019.1656483.
- Luo Y, Pan M, Ning M, Chenyu X, Liu L, Chen L, Chen T, Biyun X, Yali H, Zhou YH. High mutation prevalence of precore and basal core promoter in pregnant women who underwent spontaneous HBeAg seroconversion within one year postpartum. Dig Liver Dis. 2020;52(2):199–204. doi:10.1016/j.dld.2019.06.021.
- Luo Y, Zhang L, Dai Y, Hu Y, Xu B, Zhou YH. Conservative evolution of hepatitis B virus precore and core gene during immune tolerant phase in intrafamilial transmission. Virol Sin. 2020;35(4):388–97. doi:10.1007/s12250-020-00194-6.
- Trevisan A. Long-term persistence of immunity after hepatitis B vaccination: a fact, not a fancy. Hum Vaccin Immunother. 2017;13(4):916–17. doi:10.1080/21645515.2016.1257451.
- Ni YH, Chang MH, Jan CF, Hsu HY, Chen HL, Wu JF, Chen DS. Continuing decrease in hepatitis B virus infection 30 years after initiation of infant vaccination program in Taiwan. Clin Gastroenterol Hepatol. 2016;14(9):1324–30. doi:10.1016/j.cgh.2016.04.030.